
According to reports from The Financial Express, select small-cap stocks have performed well over the last year on better-than-expected earnings, but some stocks from the small-cap space are trading near their 52-week lows. The analysis examines three small-cap stocks that are trading close to their 52-week lows, selected based on ROE and ROCE above 20%, 3-year average profit growth of above 25%, and zero debt-to-equity ratio. However, the report emphasizes that a sharp price decline does not automatically make a stock undervalued, and investors should assess valuations, business prospects, cash flows, and industry risks before making investment decisions.
As reported by The Financial Express, Jeena Sikho Lifecare is an Indian healthcare company operating Ayurvedic hospitals, clinics and day-care centres, along with selling Ayurvedic medicines and wellness products. The stock is currently trading at ₹348, compared with its 52-week low of ₹331.8. The company demonstrates exceptional financial metrics with ROCE of 67% and ROE of 47.8%, while maintaining a zero debt-to-equity ratio. The company has recorded an impressive three-year compounded profit growth of 87.7% per annum. According to the company presentation, Jeena Sikho began FY27 on a strong footing with revenue from operations increasing 29% YoY in Q1FY27, supported by higher patient footfalls and sustained momentum in the products business.
According to The Financial Express, Indraprastha Medical Corporation operates Indraprastha Apollo Hospitals in New Delhi and specializes in multispeciality tertiary healthcare treating patients across cardiology, oncology, neurology, and nephrology. The stock is trading at ₹317, compared with its 52-week low of ₹293. The company maintains strong financial health with ROCE of 34% and ROE of 24.8%, while maintaining a zero debt-to-equity ratio. Its three-year compounded profit growth stands at 28.7%. Looking ahead, management focuses on maximizing operating efficiency and profitability across the network through greater integration, improved supply chain management, and human resource development to reduce costs of expensive drugs and medical consumables.
As reported by The Financial Express, Avanti Feeds is an Indian aquaculture company established in 1993, majoring in shrimp feed manufacturing and processed shrimp exports. The stock is trading at ₹669, compared with its 52-week low of ₹656.8. The company maintains strong fundamentals with ROCE of 20.1% and ROE of 26.9%, while maintaining a zero debt-to-equity ratio. However, on the financial front, while revenues rose, net profit fell from ₹1,849 million in Q1FY26 to ₹1,163 million YoY. According to management, the most serious emerging concern is the steep increase in shrimp feed costs, with prices of major raw materials including fish meal, fish oil, soybean meal, and wheat flour increasing significantly, resulting in substantial rise in feed costs.
According to The Financial Express, the report concludes that low share price alone does not make a stock undervalued, and investors should assess earnings consistency, return on equity (ROE), return on capital employed (ROCE), debt levels, and cash flow before making investment decisions. It's important to understand why a stock has declined and whether its business fundamentals remain intact. Strong fundamentals can improve the investment case, but they do not guarantee share-price recovery or positive returns. The analysis emphasizes that investors should conduct thorough due diligence before making investment decisions in the small-cap segment.